Navigation Links
Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
Date:7/1/2008

l trials and obtaining a premarket approval, or PMA, from the FDA. The PMA process requires Echo to prove the safety and efficacy of its tCGM system to the FDA's satisfaction. This process can be expensive and uncertain, and there is no guarantee that Echo will be able to submit a PMA for its Symphony tCGM System or that its Symphony tCGM System will be approved by the FDA in any specific timeframe or at all. In addition, clinical testing of Echo's products and eventual commercialization of its products are subject to all of the risks and uncertainties set forth in its periodic reports filed with the Securities and Exchange Commission.

These and other factors are identified and described in more detail in Echo's filings with the Securities and Exchange Commission, including, without limitation, its annual report on Form 10-KSB for the year ended December 31, 2007, its quarterly reports on Form 10-Q, and its current reports on Form 8-K. The foregoing list of factors is not exhaustive. Echo Therapeutics, Inc. undertakes no obligation to publicly update or revise any forward-looking statements.

For More Information:

Patrick T. Mooney, M.D. Lilian Stern

Chairman and Chief Executive Officer Stern Investor Relations

(856) 429-8778 (212) 362-1200


'/>"/>
SOURCE Echo Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Silence Therapeutics Announces Board Changes
2. Halozyme Therapeutics Announces That Chemophase Meets Primary Endpoint in Phase I/IIa Clinical Trial
3. Data Presented at American Headache Societys Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics Tezampanel
4. TorreyPines Therapeutics to Host Webinar at 11 a.m. EDT Today on the Opportunity for Treating Chronic Pain, Migraine and Muscle Spasticity Through Inhibition of Neurotransmitter Glutamate
5. CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Premier Registry Experienced Angina at One Year
6. Pilot Therapeutics Announces Relaunch as Gene Smart(TM) Health
7. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
8. PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity
9. Duska Therapeutics Licenses Portfolio of Heart Failure Drugs From Duke and Johns Hopkins
10. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
11. Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 31, 2014  ResMed Inc. (NYSE: RMD ) ... fiscal year ended June 30, 2014.  Revenue for the quarter ... 30, 2013 (a 1 percent decrease on a constant currency ... percent compared to the quarter ended June 30, 2013. Diluted ... of 22 percent compared to the quarter ended June 30, ...
(Date:7/31/2014)...  Cepheid (NASDAQ: CPHD ) today announced that ... invited investors to participate via webcast. ... NY Wednesday, August 13, 2014 at 9.10 a.m. ... New York, NY Thursday, September 4, 2014 ... Webcasts To access the live webcasts for these events, please ...
(Date:7/31/2014)...  UBM Medica US announces that Cancer ... presents exclusive slide shows dealing with communication in the ... care. Cancer Network, the online ... blogs, and podcasts about the latest clinical findings. Among ... , End-of-life care is challenging for even the ...
Breaking Medicine Technology:RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 2RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 3RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 4RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 5RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 6RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 7RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 8RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 9RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 10RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 11RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 12RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 13Cepheid to Webcast Upcoming Financial Presentations 2Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 2Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 3
(Date:8/1/2014)... OH (PRWEB) August 01, 2014 ... services company, announced it has joined the Pure ... has been delivering a breakthrough storage experience designed ... performance requirements of enterprise customers in diverse markets, ... and applications for more than four years. ...
(Date:8/1/2014)... HealthDay Reporter THURSDAY, July 31, 2014 ... Africa has a well-earned reputation as one of the world,s ... intense medical care can greatly improve a person,s chances of ... wreaks life-threatening havoc within the body by attacking multiple organ ... back on the basics of "good meticulous intensive care," supporting ...
(Date:8/1/2014)... FRIDAY, Aug. 1, 2014 (HealthDay News) -- Although older women ... make asthma care a priority, according to a new study. ... from asthma much more than men over 65," concluded Dr. ... of Allergy, Asthma and Immunology (ACAAI), in an organization news ... age 65 years and older is nearly four times higher ...
(Date:8/1/2014)... New research shows that people who grew up ... a 16-percent greater risk of experiencing poor health quality ... sent to prison. The finding, which accounted for other ... rate of imprisonment may be independently imparting enduring physical ... people were children when this happened, and it was ...
(Date:8/1/2014)... In the 18th and 19th Centuries, ... to the practice of medicine. Today, according to radio ... therapy has been relegated to a minor role with ... shortages, drought and pollution are creating a global health ... Power of Water host contends that hydrotherapy’s time has ...
Breaking Medicine News(10 mins):Health News:CentraComm Accepts Pure Storage Authorized Reseller Partner Invitation 2Health News:CentraComm Accepts Pure Storage Authorized Reseller Partner Invitation 3Health News:There's No Ebola Cure, But Early Intensive Treatment Boosts Survival 2Health News:There's No Ebola Cure, But Early Intensive Treatment Boosts Survival 3Health News:Older Women With Asthma Face Worse Health Outcomes 2Health News:Jailed family member increases risks for kids' adult health 2Health News:Jailed family member increases risks for kids' adult health 3Health News:Water Researcher Advocates Reevaluation of 18th and 19th Century Water Therapy Movement 2Health News:Water Researcher Advocates Reevaluation of 18th and 19th Century Water Therapy Movement 3
... , , MONDAY, Sept. 28 (HealthDay News) -- Women ... risk of developing atrial fibrillation, a potentially life-threatening irregular ... atrial fibrillation was 3.6 percent among people with type ... metabolic condition was only 2.5 percent, according to the ...
... have used nanomaterials to develop a microchip sensitive enough ... patient,s cancer so that the disease can be detected ... reported Sept. 27 in Nature Nanotechnology heralds ... "This remarkable innovation is an indication that the ...
... Ltd., a privately held medical device company focused on ... for the treatment of cancer, announced the completion of ... round included Pfizer Inc, Johnson & Johnson Development Corporation ... Pfizer, Johnson & Johnson Development Corporation and Index have ...
... new poll by the Harvard School of Public Health and The ... the state,s health reform legislation, which was enacted in 2006, support ... and 13% are not sure. The level of public support for ... saying they support the law in 2008 to 59% in the ...
... On October 2nd, 2009, Henry Gabelnick PhD, Executive ... Alan F. Guttmacher lecture at the 2009 Association ... Angeles, California. Reproductive Health 2009 is a partnership ... Parenthood Federation of America National Medical Committee, and the ...
... ... to the advisory board for PerfectServe, a healthcare communications company. , ... Knoxville, Tenn. (PRWEB) September 28, 2009 ... a healthcare communications company. The board provides guidance on innovative ways to leverage PerfectServe,s ...
Cached Medicine News:Health News:Irregular Heartbeat Risk Higher in Women With Type 2 Diabetes 2Health News:Irregular Heartbeat Risk Higher in Women With Type 2 Diabetes 3Health News:U of T researchers create microchip that can detect type and severity of cancer 2Health News:NovoCure Ltd. announces closing of financing round 2Health News:59 percent support Massachusetts' Landmark 2006 health reform law 2Health News:59 percent support Massachusetts' Landmark 2006 health reform law 3Health News:CONRAD executive director to give Guttmacher lecture at Reproductive Health 2009 2Health News:William Fuchs Named to PerfectServe Advisory Board 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: